Mars Acquires Cerba HealthCare's Stake in Cerba Vet and ANTAGENE

July 2, 2024

Mars, Incorporated has completed its acquisition of Cerba HealthCare's ownership stake in French veterinary diagnostics businesses Cerba Vet and ANTAGENE. The two businesses will join Mars Petcare's Science & Diagnostics division to complement its existing veterinary diagnostics and genetic testing capabilities.

Buyers
Mars, Incorporated
Targets
Cerba Vet, ANTAGENE
Sellers
Cerba HealthCare
Location
France
Transaction Type
Buyout

Explore More

Related Acquisitions

Build a buyer list for your deal

Find active buyers from recent acquisition patterns and move straight into outreach.